loading
Precedente Chiudi:
$9.16
Aprire:
$8.98
Volume 24 ore:
565.83K
Relative Volume:
1.10
Capitalizzazione di mercato:
$368.22M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-9.70%
1M Prestazione:
-42.66%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$7.65
$9.16
Intervallo di 1 settimana:
Value
$7.57
$9.70
Portata 52W:
Value
$3.50
$14.30

Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile

Name
Nome
Zhengye Biotechnology Holding Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ZYBT's Discussions on Twitter

Confronta ZYBT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ZYBT
Zhengye Biotechnology Holding Ltd
7.77 405.67M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.10 50.54B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
171.19 74.02B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.86 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.96 45.82B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.27 20.31B 16.54B -1.64B 749.00M -1.45

Zhengye Biotechnology Holding Ltd Borsa (ZYBT) Ultime notizie

pulisher
May 23, 2025

Zhengye Biotechnology Receives NASDAQ Delinquency Notice for Late Filing - TipRanks

May 23, 2025
pulisher
May 23, 2025

Zhengye Biotechnology faces NASDAQ compliance issue By Investing.com - Investing.com Nigeria

May 23, 2025
pulisher
May 23, 2025

Zhengye Biotechnology faces NASDAQ compliance issue - Investing.com

May 23, 2025
pulisher
May 23, 2025

Zhengye Biotechnology Holding Limited Receives NASDAQ Delinquency Letter for Non-Compliance with Listing Requirements - Nasdaq

May 23, 2025
pulisher
May 23, 2025

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewswire

May 23, 2025
pulisher
May 02, 2025

The Alternative Data Center Stocks Nobody Is Watching Right Now - Energy & Capital

May 02, 2025
pulisher
May 01, 2025

Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga

May 01, 2025
pulisher
Apr 30, 2025

Tesla, Regeneron Among Market Cap Stock Movers on Wednesday - Investing.com Australia

Apr 30, 2025
pulisher
Apr 30, 2025

Zhengye Biotechnology Holding Ltd Inc. (ZYBT) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Tesla, UnitedHealth Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa

Apr 30, 2025
pulisher
Apr 29, 2025

Zhengye Biotechnology Delays 20-F Filing - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

Spotify, Regeneron lead Tuesday’s market cap stock movers By Investing.com - Investing.com South Africa

Apr 29, 2025
pulisher
Apr 29, 2025

Timing the Bottom In Oil - Energy & Capital

Apr 29, 2025
pulisher
Apr 28, 2025

Zhengye Biotechnology Holding Ltd (ZYBT) Surges 35% - Energy & Capital

Apr 28, 2025
pulisher
Apr 27, 2025

Pre-market Movers: STSS, THRD, PTN, VRAX... - RTTNews

Apr 27, 2025
pulisher
Apr 25, 2025

The Only Nuclear Stocks to Buy Today - Energy & Capital

Apr 25, 2025
pulisher
Apr 24, 2025

Zhengye Biotechnology Holding Ltd (ZYBT): Why Shares Soared 34.91% in a Single Day - Energy & Capital

Apr 24, 2025
pulisher
Apr 23, 2025

Understanding ZYBT stock ratios for better investment decisions - uspostnews.com

Apr 23, 2025
pulisher
Apr 21, 2025

Navigating ZYBT Stock: Zhengye Biotechnology Holding Ltd Journey - investchronicle.com

Apr 21, 2025
pulisher
Apr 16, 2025

Chinese Fire Up Their Most Powerful Nuclear Plant - Energy & Capital

Apr 16, 2025
pulisher
Apr 15, 2025

If You’re Not Buying Oil Stocks Right Now, Then You Hate Money. - Energy & Capital

Apr 15, 2025
pulisher
Apr 14, 2025

Catherine De Noire Reveals Uncomfortable Truth: Prostitutes Make Excellent Financial Advisors - Energy & Capital

Apr 14, 2025
pulisher
Apr 12, 2025

Gold Is The Place To Be... Or Is It? - Energy & Capital

Apr 12, 2025
pulisher
Apr 10, 2025

Buy Oil NOW, Thank Me Later - Energy & Capital

Apr 10, 2025
pulisher
Apr 08, 2025

Warren Buffett Was Right Again, Here’s What He’s Doing Next - Energy & Capital

Apr 08, 2025
pulisher
Apr 07, 2025

A Closer Look At Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) Uninspiring ROE - simplywall.st

Apr 07, 2025
pulisher
Apr 07, 2025

Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%? - Yahoo Finance

Apr 07, 2025
pulisher
Apr 03, 2025

Zhengye Biotechnology Forms Joint Venture to Expand Poultry Vaccine Sales - TipRanks

Apr 03, 2025
pulisher
Mar 26, 2025

Nvidia, Tesla Slide Among Mega-Cap Movers on Wednesday By Investing.com - Investing.com Canada

Mar 26, 2025
pulisher
Mar 26, 2025

Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews

Mar 26, 2025
pulisher
Mar 26, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 26, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 25, 2025
pulisher
Mar 11, 2025

Kuke Music Holding Ltd ADR’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com

Mar 11, 2025
pulisher
Mar 07, 2025

Kroger CEO Questions Remain While the Market Moves on - Energy & Capital

Mar 07, 2025
pulisher
Mar 01, 2025

This Silver Stock Is Like No Other - Energy & Capital

Mar 01, 2025
pulisher
Feb 20, 2025

Trump’s Only Solution to Low Energy Prices - Energy & Capital

Feb 20, 2025
pulisher
Feb 13, 2025

Trump Vs. OPEC Round 2: The Great Oil Showdown of 2025 - Energy & Capital

Feb 13, 2025
pulisher
Feb 12, 2025

3 E Network Technology Group Ltd’s Quiet Period Will End on February 17th (NASDAQ:MASK) - Defense World

Feb 12, 2025
pulisher
Feb 12, 2025

Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World

Feb 12, 2025
pulisher
Jan 28, 2025

Data Gusher: The AI Arms Race Has Begun - Energy & Capital

Jan 28, 2025
pulisher
Jan 20, 2025

Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works

Jan 20, 2025
pulisher
Jan 14, 2025

Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire

Jan 14, 2025
pulisher
Jan 14, 2025

Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times

Jan 14, 2025
pulisher
Jan 08, 2025

Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire

Jan 08, 2025
pulisher
Jan 07, 2025

ZYBT Stock Price and Chart — NASDAQ:ZYBT - TradingView

Jan 07, 2025
pulisher
Jan 07, 2025

ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital

Jan 07, 2025
pulisher
Jan 07, 2025

Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN

Jan 07, 2025
pulisher
Jan 06, 2025

Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire

Jan 06, 2025
pulisher
Jan 05, 2025

Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World

Jan 05, 2025

Zhengye Biotechnology Holding Ltd Azioni (ZYBT) Dati Finanziari

Non sono disponibili dati finanziari per Zhengye Biotechnology Holding Ltd (ZYBT). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$8.425
price down icon 3.28%
drug_manufacturers_specialty_generic RDY
$14.62
price down icon 0.81%
$124.86
price down icon 0.01%
drug_manufacturers_specialty_generic HCM
$14.21
price up icon 2.99%
$324.39
price down icon 0.70%
$17.29
price up icon 0.03%
Capitalizzazione:     |  Volume (24 ore):